c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer
Work
Year: 2024
Type: article
Abstract: Background Endocrine therapy resistance in hormone receptor-positive/HER2-negative (HR+/HER2−) breast cancer (BC) is a significant clinical challenge that poses several unmet needs in the management ... more
Source: Breast Cancer Research
Institutions Seoul National University, Sungkyunkwan University, Samsung Medical Center, Nano-Convergence Foundation, GeneMatrix (South Korea) +1 more
Cites: 51
Cited by: 10
Related to: 10
FWCI: 7.971
Citation percentile (by year/subfield): 100
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,919
Grant ID 2022R1A2C2006322